<?xml version="1.0" encoding="UTF-8"?>
<p>Preclinical evidence. This herbal medicine has been experimentally proven for fever (
 <xref rid="B487" ref-type="bibr">Ueki et al., 2008</xref>; 
 <xref rid="B12" ref-type="bibr">Akbar, 2020</xref>). It is described in several preclinical studies report its anti-inflammatory, antipyretic and analgesic properties (
 <xref rid="B326" ref-type="bibr">Mascolo et al., 1989</xref>; 
 <xref rid="B129" ref-type="bibr">El-Abhar et al., 2008</xref>; 
 <xref rid="B440" ref-type="bibr">Sepahvand et al., 2010</xref>; 
 <xref rid="B8" ref-type="bibr">Ahmed et al., 2011</xref>; 
 <xref rid="B107" ref-type="bibr">Darvishzadeh-Mahani et al., 2012</xref>; 
 <xref rid="B240" ref-type="bibr">Hsiang et al., 2013</xref>; 
 <xref rid="B405" ref-type="bibr">Rashidian et al., 2014</xref>). The anti-inflammatory effect of ginger is wellÂ established as 
 <italic>in vivo</italic> as 
 <italic>in vitro</italic> models (
 <xref rid="B471" ref-type="bibr">Thomson et al., 2002</xref>; 
 <xref rid="B17" ref-type="bibr">Ali et al., 2008</xref>). 6-Shogaol interferes with the inflammatory cascade, inhibits COX, and the prostaglandin release (
 <xref rid="B411" ref-type="bibr">Rehman et al., 2011</xref>). Moreover, 6-gingerol and 6-shogaol present anti-platelet aggregation activity 
 <italic>in vitro</italic> (
 <xref rid="B305" ref-type="bibr">Liao et al., 2012</xref>).
</p>
